|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Ward E and Thun MJ: Recent trends
in breast cancer incidence rates by age and tumor characteristics
among U.S. women. Breast Cancer Res. 9:R282007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moore HC: An overview of
chemotherapy-related cognitive dysfunction, or ‘chemobrain’.
Oncology (Williston Park). 28:797–804. 2014.PubMed/NCBI
|
|
5
|
Zheng Y, Luo J, Bao P, Cai H, Hong Z, Ding
D, Jackson JC, Shu XO and Dai Q: Long-term cognitive function
change among breast cancer survivors. Breast Cancer Res Treat.
146:599–609. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bompaire F, Durand T, Léger-Hardy I,
Psimaras D and Ricard D: Chemotherapy-related cognitive impairment
or ‘chemobrain’: concept and state of art. Geriatr Psychol
Neuropsychiatr Vieil. 15:89–98. 2017.PubMed/NCBI
|
|
7
|
Heck JE, Albert SM, Franco R and Gorin SS:
Patterns of dementia diagnosis in surveillance, epidemiology, and
end results breast cancer survivors who use chemotherapy. J Am
Geriatr Soc Sep. 56:1687–1692. 2008. View Article : Google Scholar
|
|
8
|
Jay TM, Rocher C, Hotte M, Naudon L,
Gurden H and Spedding M: Plasticity at hippocampal to prefrontal
cortex synapses is impaired by loss of dopamine and stress:
Importance for psychiatric diseases. Neurotox Res. 6:233–244. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pecori Giraldi F, Moro M and Cavagnini F;
Study Group on the Hypothalamo-Pituitary-Adrenal Axis of the
Italian Society of Endocrinology, : Gender-related differences in
the presentation and course of Cushing's disease. J Clin Endocrinol
Metab. 88:1554–1558. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsolaki M: Post traumatic stress dementia:
A new target for cholinesterase inhibitors. Neurobiol Aging.
25:26–27. 2004.
|
|
11
|
Boehmke MM and Dickerson SS: Symptom,
symptom experiences, and symptom distress encountered by women with
breast cancer undergoing current treatment modalities. Cancer Nurs.
28:382–389. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Günüşen NP, İnan FŞ and Üstün B:
Experiences of Turkish women with breast cancer during the
treatment process and facilitating coping factors. Asian Pac J
Cancer Prev. 14:3143–3149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hinnen C, Ranchor AV, Sanderman R,
Snijders TA, Hagedoorn M and Coyne JC: Course of distress in breast
cancer patients, their partners, and matched control couples. Ann
Behav Med. 36:141–148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hoskins CN: Breast cancer
treatment-related patterns in side effects, psychological distress,
and perceived health status. Oncol Nurs Forum. 24:1575–1583.
1997.PubMed/NCBI
|
|
15
|
Berhili S, Kadiri S, Bouziane A, Aissa A,
Marnouche E, Ogandaga E, Echchikhi Y, Touil A, Loughlimi H, Lahdiri
I, et al: Associated factors with psychological distress in
Moroccan breast cancer patients: A cross-sectional study. Breast.
31:26–33. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Murman DL: The impact of age on cognition.
Semin Hear. 36:111–121. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oh H, Mormino EC, Madison C, Hayenga A,
Smiljic A and Jagust WJ: β-amyloid affects frontal and posterior
brain networks in normal aging. Neuroimage. 54:1887–1895. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dennis EL and Thompson PM: Functional
brain connectivity using fMRI in aging and Alzheimer's disease.
Neuropsychol Rev. 24:49–62. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wisdom NM, Mignogna J and Collins RL:
Variability in Wechsler Adult Intelligence Scale-IV subtest
performance across age. Arch Clin Neuropsychol. 27:389–397. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oosterman JM, Vogels RL, van Harten B,
Gouw AA, Poggesi A, Scheltens P, Kessels RP and Scherder EJ:
Assessing mental flexibility: Neuroanatomical and
neuropsychological correlates of the Trail Making Test in elderly
people. Clin Neuropsychol. 24:203–219. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park DC and Festini SB: Theories of memory
and aging: A look at the past and a glimpse of the future. J
Gerontol B Psychol Sci Soc Sci. 72:82–90. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gosain R, Pollock Y and Jain D:
Age-related disparity: Breast cancer in the elderly. Curr Oncol
Rep. 18:692016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sinha S, Panebianco L, Wu X, Wang D, Huang
D and Sivapiragasam A: Abstract GS2-02: Efficacy and utilization
trends of adjuvant chemotherapy for stage I, II, and III breast
cancer in the elderly population: A National Cancer Database (NCDB)
analysis. San Antonio Breast Cancer Symposium (San Antonio).
2018.
|
|
24
|
Moher D, Liberati A, Tetzlaff J and Altman
DG; the PRISMA Group, : Preferred reporting items for systematic
reviews and meta-analyses: The PRISMA statement. PLoS Medicine.
6:e10000972009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wells GA, Shea B, O'Connell D, Peterson J,
Welch V, Losos M and Tugwell P: The Newcastle-Ottawa Scale (NOS)
for assessing the quality of nonrandomised studies in metaanalyses.
Ottawa Health Research Institute. (Ottawa). 1999.
|
|
26
|
Menning S, de Ruiter MB, Kieffer JM,
Agelink van Rentergem J, Veltman DJ, Fruijtier A, Oldenburg HS,
Boven E, van der Meij S, Lustig V, et al: Cognitive impairment in a
subset of breast cancer patients after systemic therapy-results
from a longitudinal study. J Pain Symptom Manage. 52:560–569.e1.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Andreano JM, Waisman J, Donley L and
Cahill L: Effects of breast cancer treatment on the hormonal and
cognitive consequences of acute stress. Psychooncology.
21:1091–1098. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Calvio L, Peugeot M, Bruns GL, Todd BL and
Feuerstein M: Measures of cognitive function and work in
occupationally active breast cancer survivors. J Occup Environ Med.
52:219–227. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Debess J, Riis JØ, Pedersen L and Ewertz
M: Cognitive function and quality of life after surgery for early
breast cancer in North Jutland, Denmark. Acta Oncol. 48:532–540.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Levkovich I, Cohen M, Alon S, Kuchuk I,
Nissenbaum B, Evron E, Pollack S and Fried G: Symptom cluster of
emotional distress, fatigue and cognitive difficulties among young
and older breast cancer survivors: The mediating role of subjective
stress. J Geriatr Oncol. 9:469–475. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Henneghan A, Stuifbergen A, Becker H,
Kesler S and King E: Modifiable correlates of perceived cognitive
function in breast cancer survivors up to 10 years after
chemotherapy completion. J Cancer Surviv. 12:224–233. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kamen C, Scheiber C, Janelsins M, Jo B,
Shen H and Palesh O: Effects of childhood trauma exposure and
cortisol levels on cognitive functioning among breast cancer
survivors. Child Abuse Negl. 72:163–171. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hermelink K, Bühner M, Sckopke P, Neufeld
F, Kaste J, Voigt V, Münzel K, Wuerstlein R, Ditsch N, Hellerhoff
K, et al: Chemotherapy and post-traumatic stress in the causation
of cognitive dysfunction in breast cancer patients. J Natl Cancer
Inst. May 3–2017.(Epub ahead of print). doi:
https://doi.org/10.1093/jnci/djx057. View Article : Google Scholar
|
|
34
|
Reyes-Gibby CC, Anderson KO, Morrow PK,
Shete S and Hassan S: Depressive symptoms and health-related
quality of life in breast cancer survivors. J Womens Health
(Larchmt). 21:311–318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ehlers DK, Aguiñaga S, Cosman J, Severson
J, Kramer AF and McAuley E: The effects of physical activity and
fatigue on cognitive performance in breast cancer survivors. Breast
Cancer Res Treat. 165:699–707. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang H, Brand JS, Fang F, Chiesa F,
Johansson AL, Hall P and Czene K: Time-dependent risk of
depression, anxiety, and stress-related disorders in patients with
invasive and in situ breast cancer. Int J Cancer. 140:841–852.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
McDermott LM and Ebmeier KP: A
meta-analysis of depression severity and cognitive function. J
Affect Disord. 119:1–8. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim JI, Song Y, Lee JH, Kim HJ, Hong EJ,
Kim SA, Jun YS and Chang OJ: Depression, stress and self-esteem
according to treatment phase in patients with breast cancer. Indian
J Sci Technol. 8:1–7. 2015. View Article : Google Scholar
|
|
39
|
Franzen MD: Practical and methodological
considerations regarding reliability. In: Reliability and Validity
in Neuropsychological Assessment. Springer Science and Business
Media. (New York, NY). 15–26. 2013.
|
|
40
|
Fan HG, Houédé-Tchen N, Yi QL, Chemerynsky
I, Downie FP, Sabate K and Tannock IF: Fatigue, menopausal
symptoms, and cognitive function in women after adjuvant
chemotherapy for breast cancer: 1- and 2-year follow-up of a
prospective controlled study. J Clin Oncol. 23:8025–8032. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schilder CM, Seynaeve C, Beex LV, Boogerd
W, Linn SC, Gundy CM, Huizenga HM, Nortier JW, van de Velde CJ, van
Dam FS, et al: Effects of tamoxifen and exemestane on cognitive
functioning of postmenopausal patients with breast cancer: Results
from the neuropsychological side study of the tamoxifen and
exemestane adjuvant multinational trial. J Clin Oncol.
28:1294–1300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Silverman DH, Dy CJ, Castellon SA, Lai J,
Pio BS, Abraham L, Waddell K, Petersen L, Phelps ME and Ganz PA:
Altered frontocortical, cerebellar, and basal ganglia activity in
adjuvant-treated breast cancer survivors 5–10 years after
chemotherapy. Breast Cancer Res Treat. 103:303–311. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
de Ruiter MB, Reneman L, Boogerd W,
Veltman DJ, Caan M, Douaud G, Lavini C, Linn SC, Boven E, van Dam
FS, et al: Late effects of high-dose adjuvant chemotherapy on white
and gray matter in breast cancer survivors: Converging results from
multimodal magnetic resonance imaging. Hum Brain Mapp.
33:2971–2983. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pelekasis P, Matsouka I and Koumarianou A:
Progressive muscle relaxation as a supportive intervention for
cancer patients undergoing chemotherapy: A systematic review.
Palliat Support Care. 15:465–473. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pelekasis P, Zisi G, Koumarianou A,
Marioli A, Chrousos G, Syrigos K and Darviri C: Forming a stress
management and health promotion program for women undergoing
chemotherapy for breast cancer: A pilot randomized controlled
trial. Integr Cancer Ther. 15:165–174. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Maizes V, Rakel D and Niemiec C:
Integrative medicine and patient-centered care. Explore (NY).
5:277–289. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cimprich B, So H, Ronis DL and Trask C:
Pre-treatment factors related to cognitive functioning in women
newly diagnosed with breast cancer. Psychooncology. 14:70–78. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wefel JS, Lenzi R, Theriault R, Buzdar AU,
Cruickshank S and Meyers CA: ‘Chemobrain’ in breast carcinoma?: A
prologue. Cancer. 101:466–475. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hermelink K, Untch M, Lux MP, Kreienberg
R, Beck T, Bauerfeind I and Münzel K: Cognitive function during
neoadjuvant chemotherapy for breast cancer: Results of a
prospective, multicenter, longitudinal study. Cancer.
109:1905–1913. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Schagen SB, Muller MJ, Boogerd W,
Mellenbergh GJ and van Dam FS: Change in cognitive function after
chemotherapy: a prospective longitudinal study in breast cancer
patients. J Natl Cancer Inst. 98:1742–5. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Stewart A, Bielajew C, Collins B,
Parkinson M and Tomiak E: A meta-analysis of the neuropsychological
effects of adjuvant chemotherapy treatment in women treated for
breast cancer. Clin Neuropsychol. 20:76–89. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Héry C, Ferlay J, Boniol M and Autier P:
Quantification of changes in breast cancer incidence and mortality
since 1990 in 35 countries with Caucasian-majority populations. Ann
Oncol. 19:1187–1194. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Franzen MD: Validity as applied to
neuropsychological assessment. In: Reliability and Validity in
Neuropsychological Assessment. Springer Science and Business Media.
(New York, NY). 33–54. 2013.
|
|
54
|
Hellhammer DH, Wüst S and Kudielka BM:
Salivary cortisol as a biomarker in stress research.
Psychoneuroendocrinology. 34:163–171. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wu SM, Yang HC, Thayer JF and Andersen BL:
Association of the physiological stress response with depressive
symptoms in patients with breast cancer. Psychosom Med. 76:252–256.
2014. View Article : Google Scholar : PubMed/NCBI
|
